Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction

Myocardium Infarction (MI) is one of the foremost cardiovascular diseases (CVDs) causing death worldwide, and its case numbers are expected to continuously increase in the coming years. Pharmacological interventions have not been at the forefront in ameliorating MI-related morbidity and mortality. S...

Description complète

Détails bibliographiques

Auteurs principaux:	Vineeta Sharma, Sanat Kumar Dash, Kavitha Govarthanan, Rekha Gahtori, Nidhi Negi, Mahmood Barani, Richa Tomar, Sudip Chakraborty, Santosh Mathapati, Dillip Kumar Bishi, Poonam Negi, Kamal Dua, Sachin Kumar Singh, Rohit Gundamaraju, Abhijit Dey, Janne Ruokolainen, Vijay Kumar Thakur, Kavindra Kumar Kesari, Niraj Kumar Jha, Piyush Kumar Gupta, Shreesh Ojha
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2021-09-01
Collection:	Cells
Sujets:	myocardial infarction stem cells regeneration biomaterial cardiomyocytes tissue engineering
Accès en ligne:	https://www.mdpi.com/2073-4409/10/10/2538
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!